5 Results for "

Sutezolid

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Sutezolid" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-10392
CAS No.: 168828-58-8
Purity:  99.40%
Synonyms: PNU-100480; U-100480; PF-02341272
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Sutezolid (PNU-100480), an orally active oxazolidinone antimicrobial agent, acts by inhibiting bacterial protein synthesis. Sutezolid has potent activity against mycobacteria, and is used for the research of drug-resistant tuberculosis .
loading...
    loading...
Cat. No.: HY-125941
CAS No.: 168828-60-2
Purity:  98.83%
Target:  

Bacterial

Research Areas:  

Infection

PNU-101603 is a sulfoxide metabolite of Sutezolid (HY-10392). PNU-101603 alone or combined with SQ109 (HY-14989) shows excellent activity against Mycobacterium tuberculosis (MTB), as well as against agent-susceptible and multidrug-resistant TB .
loading...
    loading...
Cat. No.: HY-10392R
CAS No.: 168828-58-8
Synonyms: PNU-100480 (Standard); U-100480 (Standard); PF-02341272 (Standard)
Research Areas:  

Infection

Sutezolid (Standard) is the analytical standard of Sutezolid. This product is intended for research and analytical applications. Sutezolid (PNU-100480), an orally active oxazolidinone antimicrobial agent, acts by inhibiting bacterial protein synthesis. Sutezolid has potent activity against mycobacteria, and is used for the research of drug-resistant tuberculosis[1][2].
loading...
    loading...
Cat. No.: HY-10392S
Synonyms: PNU-100480-13C4; U-100480-13C4; PF-02341272-13C4
Sutezolid- 13C4 (PNU-100480- 13C4) is 13C labeled Sutezolid. Sutezolid (PNU-100480), an orally active oxazolidinone antimicrobial agent, acts by inhibiting bacterial protein synthesis. Sutezolid has potent activity against mycobacteria, and is used for the research of drug-resistant tuberculosis .
loading...
    loading...
Cat. No.: HY-179649
CAS No.: 484026-63-3
Target:  

Bacterial

Research Areas:  

Infection

sALT629 is an orally active antitubercular agent with potent intramacrophage activity (EC50 = 1.5 μM). sALT629 shows broad-spectrum anti-Mycobacterium tuberculosis (Mtb) activities across four carbon sources, equipotent efficacy against drug-resistant Mtb, and activity against both slow-replicating and nonreplicating Mtb. sALT629 exhibits synergistic activity when combined with oxazolidinone drugs, such as Linezolid (HY-10394) and Sutezolid (HY-10392). sALT629 can be used for the research of tuberculosis .
loading...
    loading...